2015 Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside is VPGMarketResearchs new seven-country report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the global coagulation testing market during the next five years.
The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
France, Germany, Italy, Japan, Spain, UK, USA
Worldwide Market Overview
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
- Estimated universe of facilities performing coagulation tests
- Five-year test volume and sales projections by country.
Business Opportunities and Strategic Recommendations
- Product development and business expansion
opportunities with significant market appeal.
- Ideal product models with tentative
prices and operating characteristics.
- Alternative market penetration
strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
Current and Emerging Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand`s Factor Fav/Ag, and others.
Sales and Market Share Analysis of Instrument and Reagent Suppliers
- Sales and market shares of major instrument
and consumable manufactures by country.
Market Segmentation Analysis
- Comprehensive market
segmentation analysis, including:
- Commercial/Private Laboratories
- Physician Offices
- Ambulatory Care Centers
- Test volume forecasts for over 40 major procedures,
by country and market segment.
Current and Emerging Products
- Review of established and new procedures.
- Comparison of automated and semi-automated
analyzers marketed by Diagnostica Stago, Helena, IL,
Roche, Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies
and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
- Strategic assessments ofmajor suppliers and start-up firms
developing innovative coagulation testing technologies
and products, including their sales, product portfolios,
marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
- ADI/American Diagnostica
- Beckman Coulter/Danaher
- Becton Dickinson
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Thermo Fisher
Contains 650 pages and 150 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch.com provides analysis of Digoxin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care ...
July 2016 | $0 | View Details >>
The North America Allergic Rhinitis Therapeutic Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Allergic Rhinitis Therapeutic industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Allergic Rhinitis Therapeutic market analysis ...
February 2016 | $3800 | View Details >>
This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers ...
November 2015 | $0 | View Details >>
2017 Peru Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
January 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research